Open Access
Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2
Oncology Research · 2026 · 34 (5) · 1-10
DOI: 10.32604/or.2026.081624 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Oncology Research Editorial Office. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
[This retracts the article DOI: 10.3727/096504019X15615433287579.].
Zitieren
APA
Oncology Research Editorial Office (2026). Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2. Oncology Research, 34(5), 1-10. https://doi.org/10.32604/or.2026.081624
Vancouver
Oncology Research Editorial Office. Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2. Oncology Research. 2026;34(5):1-10. doi:10.32604/or.2026.081624
BibTeX
@article{OncologyResearchEditorialOffice2026,
author = {Oncology Research Editorial Office, Oncology Research Editorial Office},
title = {Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2},
journal = {Oncology Research},
year = {2026},
volume = {34},
number = {5},
pages = {1--10},
doi = {10.32604/or.2026.081624}
}
EUVIMED